Archived News
In August 2021 Finfeed changed from a website that covered ASX listed news to a website
that covered a select range of ASX
listed small cap Biotech stocks that we are personally
invested in: find out more.
The old Finfeed website, and all of the old articles are kept here for record keeping purposes.
VISIT NEW SITEOneview deploys new technology with five-year contract
3 minute read
In a development that is likely to propel Oneview Healthcare Plc’s (ASX:ONE) shares even higher, the health-tech group signed a 5-year contract extension with Epworth HealthCare, the largest private health service in Victoria.
Not only is this positive news from a financial perspective in terms of contributing to the company’s long-term visible income stream, as Epworth stands as Oneview’s largest customer in Australia and second largest globally by number of beds, it represents a strong endorsement of the company’s products and services.
The Oneview platform is currently deployed across eight Epworth hospital locations in approximately 1,440 beds.
Epworth will also be expanding the footprint with Oneview in its redevelopment at Epworth Eastern at Box Hill with an additional 63 beds.
Oneview’s shares have increased nearly 500% in the last three months, but with this development providing a significant financial boost and the prospect of further contract flow adding momentum, it wouldn’t be surprising to see the company break above this year’s record closing high of 46 cents struck in mid-April.
Deployment of new technology and increased footprint
As part of the contract renewal, Epworth will be migrating to Oneview’s new Next Generation CXP Enterprise platform and deploying GMS certified healthcare grade 22” Android devices across its diverse care settings.
By way of background, Oneview Healthcare provides digital tools for patients, families, and caregivers to improve the care experience.
By unifying a facility’s systems, content and services into one digital platform with dedicated devices at the point of care, Oneview helps deliver more control for patients and families, more time for care teams, and less complexity for executives and IT teams.
The company’s products have been embraced on the international stage, partnering with leading healthcare systems in the US, Australia, the Middle East and Asia.
Win-win situation between tech provider and health care client
Discussing the nature of the complementary relationship between Oneview and Epworth, chief executive James Fitter said, “We have enjoyed a very special partnership with Epworth dating back to our initial deployment at Epworth Eastern in Box Hill in January 2015.
"They have been the inspiration for much of our innovation in the Australian market and encouraged us to broaden the platform to include an extensive suite of care team applications which have become an integral part of their care delivery model.”
Highlighting the benefits of Oneview's technologies in the patient care environment, Dr Lachlan Henderson, group chief executive, Epworth HealthCare said, ‘’The agreement will enable Epworth to take digital healthcare into the future.
"The Oneview point-of-care platform has changed the way we deliver care to patients, as well as providing our patients with a unique entertainment and connected experience.
"Our nurses and doctors access our Oneview point of care screens 20,000 times a day, allowing them to update patient information and access medical imaging, radiology and pathology results, at the bedside.
"Patients can also see information about their care and discharge plan.”
Latest articles on Oneview Healthcare plc
More Commentary
FYI establishes ties with independent ESG reporting platform
01-07-2021
Australian Government Awards FYI National Project Status
29-06-2021
AHI and Nexus-Vita to fast track integration
22-06-2021
Oneview signs long-term contract with a second Victorian hospital
18-06-2021S3 Consortium Pty Ltd (CAR No.433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information only. Any advice is general advice only. Neither your personal objectives, financial situation nor needs have been taken into consideration. Accordingly you should consider how appropriate the advice (if any) is to those objectives, financial situation and needs, before acting on the advice.
Conflict of Interest Notice
S3 Consortium Pty Ltd does and seeks to do business with companies featured in its articles. As a result, investors should be aware that the Firm may have a conflict of interest that could affect the objectivity of this article. Investors should consider this article as only a single factor in making any investment decision. The publishers of this article also wish to disclose that they may hold this stock in their portfolios and that any decision to purchase this stock should be done so after the purchaser has made their own inquires as to the validity of any information in this article.
Publishers Notice
The information contained in this article is current at the finalised date. The information contained in this article is based on sources reasonably considered to be reliable by S3 Consortium Pty Ltd, and available in the public domain.